Tarsus Pharmaceuticals, Inc. (TARS) Ownership

$48.09

north_east
$1.62 (3.49%)
Day's range
$45.6
Day's range
$48.21

Tarsus Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 3.54 M $195.95 M   -5.77% 9.22%
RTW INVESTMENTS, LP 02/14/2025 3.24 M $179.21 M   -5.16% 8.43%
PARADIGM BIOCAPITAL ADVISORS LP 02/14/2025 2.53 M $140.19 M   3.75% 6.60%
JENNISON ASSOCIATES LLC 01/24/2025 2.50 M $138.43 M   14.76% 6.51%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 2.25 M $124.85 M   0.00% 5.87%
VANGUARD GROUP INC 02/11/2025 2.12 M $117.12 M   0.85% 5.51%
TORONTO DOMINION BANK 02/19/2025 1.91 M $105.71 M   100.00% 4.97%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/18/2025 1.59 M $87.90 M   0.00% 4.14%
LORD, ABBETT & CO. LLC 02/14/2025 1.28 M $70.87 M   115.17% 3.33%
ASSENAGON ASSET MANAGEMENT S.A. 01/14/2025 1.15 M $63.50 M   0.49% 2.99%
INVESCO LTD. 02/13/2025 932,115 $51.61 M   36.65% 2.43%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 838,804 $46.46 M   0.36% 2.19%
MACQUARIE GROUP LTD 02/14/2025 815,912 $45.18 M   37.16% 2.13%
ARTISAN PARTNERS LIMITED PARTNERSHIP 02/12/2025 691,299 $38.28 M   -2.50% 1.80%
MILLENNIUM MANAGEMENT LLC 02/14/2025 644,010 $35.66 M   189.42% 1.68%
IKARIAN CAPITAL, LLC 02/14/2025 607,689 $33.65 M   -41.02% 1.58%
ENSIGN PEAK ADVISORS, INC 02/14/2025 570,056 $31.56 M   -2.89% 1.49%
CORMORANT ASSET MANAGEMENT, LP 02/14/2025 500,000 $27.69 M   0.00% 1.30%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 460,773 $25.51 M   92.54% 1.20%
JEFFERIES FINANCIAL GROUP INC. 02/27/2025 420,758 $23.30 M   0.00% 1.10%
GILDER GAGNON HOWE & CO LLC 02/14/2025 404,237 $22.38 M   5,636.30% 1.05%
D. E. SHAW & CO., INC. 02/14/2025 365,544 $20.24 M   100.74% 0.95%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 02/14/2025 350,000 $19.38 M   -6.67% 0.91%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 341,305 $18.90 M   -15.51% 0.89%
GOLDMAN SACHS GROUP INC 02/11/2025 318,730 $17.65 M   18.59% 0.83%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 293,700 $16.26 M   1.27% 0.77%
JANE STREET GROUP, LLC 02/14/2025 266,600 $14.76 M   100.00% 0.69%
AIGH CAPITAL MANAGEMENT LLC 02/12/2025 224,713 $12.44 M   9.93% 0.59%
TFG ASSET MANAGEMENT GP LTD 02/21/2025 200,000 $11.07 M   -67.43% 0.52%
PERCEPTIVE ADVISORS LLC 02/14/2025 186,662 $10.34 M   -85.60% 0.49%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/29/2025 181,122 $10.03 M   -13.97% 0.47%
ATIKA CAPITAL MANAGEMENT LLC 02/13/2025 177,200 $9.81 M   100.00% 0.46%
ALLY BRIDGE GROUP (NY) LLC 02/14/2025 173,144 $9.59 M   -46.21% 0.45%
SANDS CAPITAL VENTURES, LLC 02/13/2025 170,000 $9.41 M   0.00% 0.44%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 156,403 $8.66 M   -43.24% 0.41%
DEUTSCHE BANK AG\ 02/14/2025 153,441 $8.50 M   93.82% 0.40%
PRUDENTIAL FINANCIAL INC 02/11/2025 148,735 $8.24 M   43.71% 0.39%
BAIRD FINANCIAL GROUP, INC. 02/14/2025 142,419 $7.89 M   -2.74% 0.37%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 136,795 $7.57 M   -5.88% 0.36%
J. GOLDMAN & CO LP 02/14/2025 130,195 $7.21 M   -76.65% 0.34%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 02/05/2025 130,097 $7.20 M   -0.27% 0.34%
JPMORGAN CHASE & CO 02/12/2025 129,184 $7.15 M   -70.65% 0.34%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 125,539 $6.95 M   -10.79% 0.33%
CUTTER CAPITAL MANAGEMENT, LP 02/14/2025 112,500 $6.23 M   100.00% 0.29%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 110,889 $6.14 M   100.00% 0.29%
WOODLINE PARTNERS LP 02/14/2025 108,986 $6.03 M   52.28% 0.28%
BANK OF NEW YORK MELLON CORP 02/04/2025 101,928 $5.64 M   0.49% 0.27%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 97,996 $5.43 M   51.50% 0.26%
LISANTI CAPITAL GROWTH, LLC 02/07/2025 96,935 $5.37 M   143.28% 0.25%
ABRDN PLC 01/24/2025 93,650 $5.19 M   -8.68% 0.24%

Tarsus Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 207 institutional investors and hedge funds held shares of Tarsus Pharmaceuticals, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 3.54 M

RTW INVESTMENTS, LP: 3.24 M

Paradigm Biocapital Advisors LP: 2.53 M

JENNISON ASSOCIATES LLC: 2.5 M

TANG CAPITAL MANAGEMENT LLC: 2.25 M

VANGUARD GROUP INC: 2.12 M

104.51% of Tarsus Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 45.78 M shares in the last 24 months. This purchase volume represents approximately $2.20 B in transactions.